Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$447.09M
Total Bought:
$107.24M
Total Sold:
$54.55M
Net Transaction:
+$52.69M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Skye Bioscience, Inc.(SKYE)010,179,505+10,179,505$0$81.54M18.24%+$81.54M
Entrada Therapeutics, Inc.(TRDA)4,408,3794,408,3790$62.47M$62.82M14.05%+$352.7K
Enliven Therapeutics Inc3,835,9752,610,875-1,225,100$67.47M$61.02M13.65%-$6.46M
Dianthus Therapeutics, Inc.(DNTH)1,242,0291,232,965-9,064$37.26M$31.91M7.14%-$5.35M
Celldex Therapeutics, Inc.(CLDX)497,270497,2700$20.87M$18.40M4.12%-$2.47M
Biohaven Ltd.(BHVN)319,972469,972+150,000$17.50M$16.31M3.65%-$1.19M
Tyra Biosciences, Inc.(TYRA)939,298939,2980$15.40M$15.02M3.36%-$385.1K
Pharvaris N V
COM
797,600797,6000$18.43M$14.99M3.35%-$3.44M
Praxis Precision Medicines, Inc.(PRAX)340,000340,0000$20.75M$14.06M3.15%-$6.68M
Erasca, Inc.(ERAS)05,405,404+5,405,404$0$12.76M2.85%+$12.76M
Viking Therapeutics, Inc.(VKTX)237,560237,5600$19.48M$12.59M2.82%-$6.89M
MoonLake ImmunotherapeuticsCL A(MLTX)282,313282,3130$14.18M$12.41M2.78%-$1.77M
Centessa Pharmaceuticals PlcADS1,245,0001,245,0000$14.07M$11.24M2.51%-$2.83M
Tectonic Therapeutic, Inc.(TECX)0646,524+646,524$0$10.65M2.38%+$10.65M
Viridian Therapeutics, Inc.(VRDN)736,595736,5950$12.90M$9.58M2.14%-$3.31M
Silence Therapeutics plcADS(SLN)476,200476,2000$10.29M$9.05M2.02%-$1.24M
Anaptysbio Inc357,733357,7330$8.06M$8.96M2.01%+$908.6K
GH Research PLC(GHRS)572,665572,6650$6.10M$6.68M1.49%+$572.7K
Cogent Biosciences, Inc.(COGT)790,440790,4400$5.31M$6.66M1.49%+$1.35M
Vor Biopharma Inc.(VOR)6,361,7236,361,7230$15.08M$6.36M1.42%-$8.72M
Scpharmaceuticals Inc1,200,6471,200,6470$6.03M$5.22M1.17%-$804.4K
Rallybio Corporation(RLYB)3,630,7243,630,7240$6.72M$4.87M1.09%-$1.85M
Q32 Bio Inc.(QTTB)251,994251,9940$4.29M$4.52M1.01%+$229.3K
Adverum Biotechnologies Inc541,666541,6660$7.66M$3.72M0.83%-$3.94M
Mersana Therapeutics Inc1,305,0001,305,0000$5.85M$2.62M0.59%-$3.22M
Zentalis Pharmaceuticals, Inc.(ZNTL)490,000490,0000$7.72M$2.00M0.45%-$5.72M
Cidara Therapeutics Inc056,725+56,725$0$677.3K0.15%+$677.3K
EyePoint, Inc.(EYPT)050,000+50,000$0$435.0K0.10%+$435.0K
Avidity Biosciences Inc665,5550-665,555$16.98M$0—-$16.98M
Cidara Therapeutics Inc1,134,5110-1,134,511$1.04M$0—-$1.04M
Merus N V548,8250-548,825$24.71M$0—-$24.71M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q2 2024 | TickerTrail